Results for tag: "Prader Willi Syndrome Drug"

Prader Willi Syndrome (PWS) is a rare genetic disorder that affects appetite, growth, metabolism, cognitive function, and behavior. Endocrine and Metabolic Disorders Drugs are used to treat the symptoms of PWS, including growth hormone therapy, appetite suppressants, and medications to improve cognitive function. Endocrine and Metabolic Disorders Drugs are also used to manage the metabolic and hormonal imbalances associated with PWS. The Prader Willi Syndrome Drug market is a specialized market that focuses on the development of drugs to treat the symptoms of PWS. The market is driven by the increasing prevalence of PWS, as well as the need for improved treatments. Companies in the market include Novo Nordisk, Pfizer, and Sanofi, which are all major players in the Endocrine and Metabolic Disorders Drugs market. Other companies in the market include Biomarin, Shire, and Takeda, which specialize in the development of drugs for rare diseases. Show Less Read more